Attendance rise sees CPhI & P-MEC India 2018 move to Indian capital

The India Expo Mart brings the event closer to Indian regulatory and legislative hub and will encourage international audiences

 

Amsterdam, 11 June 2018:  CPhI & P-MEC India (December 10-14, 2018) – organised by UBM – announces that the 12th edition of Asia’s largest Pharma exhibition is moving to the India Expo Mart, New Delhi. The new venue will see the exhibition now hosted in a single venue, bringing it closer to the Indian regulatory and legislative capital. New Delhi is also the country’s main international transport hub and will encourage an increased international attendance. In total, more than 50,000 people from 122 countries are expected, along with nearly 1,500 exhibitors.

CPhI & P-MEC India comes with the backing of the Delhi-based Pharmaceuticals Export Promotion Council of India (Pharmexcil) – the organisation behind key Government international strategies such as ‘Made in India’. Mr. Yogesh Mudras, Managing Director, UBM India commented “the shift to the Delhi-NCR region, in close geographical proximity to the policy makers, consulates and government bodies will enhance our community building efforts, as well as the creation of a robust pharma eco-system.” 

Government investment plans including a US$ 640 million venture capital fund to boost drug discovery and strengthen pharmaceutical infrastructure – and the ‘Pharma Vision 2020’ initiative are creating new benefits for government engagement with industry. 

UBM cited rising international interest in the event as a key factor in the move, with numbers of both international and domestic exhibitors requiring a far bigger venue – and on a single site. 

Mr Mudras added “I am delighted that CPhI & P-MEC India will be held this year at India Expo Mart, Greater Noida – it’s the flagship platform for the Indian pharma industry and one of the world’s leading Pharmaceutical networking events. It’s also a major international hub, with India’s largest airport, and this venue change is looking ahead to future audience needs. 

The venue change is also seen as a boost to domestically focused markets by bringing a wider remit of attendees and greater access to national regulatory pathways. The country registers the second largest Abbreviated New Drug Applications (ANDAs) globally and is the world’s leader in Drug Master Files (DMFs) applications, so access to regulatory expertise has never been greater.

The 2018 edition will also feature India Pharma Week (returning for a third year), with 10 unique events and activities spanning the Indian Capital. These include dynamic engagements such as the Pharma Leader’s Golf Pre-Connect Congress, Plant Visits, Women in Pharma – Power Breakfast, India Pharma Awards, Networking Evening, and a closed-door CEO Roundtable, amongst others. 

The ultimate goal of all these intertwined events is to help nurture a complete pharma ecosystem in India and better enable networking with the country’s corridors of power. In fact, the recent CPhI Global Pharma Index showed India represents global pharma’s second fastest growing market and praised the Delhi based regulator, the CDSCO (Central Drugs Standard Control Organization) for its efforts in introducing a certification programme and initiatives for increased compliance. Impressively, 52% of international respondents believed the CDSCO is moving toward comparability with the regulatory standards of the EMA and FDA.

 

 - ENDS-

 

Notes to editors

 

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, North America, Korea, China, India, Japan, Southeast Asia and the Middle East, and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, FDF for finished dosage formulations, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.

 

For more information visit: www.cphi.com

 

The UBM annual schedule of Pharmaceutical events includes: CPhI and P-MEC China (20-22 June, 2018 at SNIEC – Shanghai, China); CPhI Korea (28-30 August 2018, COEX, Seoul, Korea); CPhI Middle East & Africa (3-5 September, 2018 at the ADNEC – Abu Dhabi, United Arab Emirates). BioLIVE (9-11, October, 2018 in Madrid); CPhI, ICSE, P-MEC, FDF and InnoPack Worldwide (9-11 October, 2018 at the IFEMA, Feria de Madrid – Madrid, Spain); CPhI & P-MEC India (3–6 December 2018 at the BEC and BKC Exhibition and Convention Centres – Mumbai, India); Pharmapack Europe (6-7 February, 2019 at the Paris Expo, Porte de Versailles – Paris, France); CPhI, P-MEC, ICSE, FDF, Labworld and Innopack South East Asia (18-20 March, 2019 – Bangkok, Thailand). CPhI, ICSE, FDF and InnoPack North America (30 April - 2 May, 2019 at the Pennsylvania Convention Center – Philadelphia, USA)

 

About UBM

UBM is the largest pure-play B2B Events organizer in the world. Our 3,750+ people, based in more than 20 countries, serve more than 50 different sectors. Our deep knowledge and passion for these sectors allow us to create valuable experiences which enable our customers to succeed. Please visit www.ubm.com for the latest news and information about UBM. CPhI, ICSE, P-MEC, BioPh and InnoPack Japan (18-20 April, 2018 at the Big Sight Exhibition Centre – Tokyo, Japan); CPhI, ICSE, FDF and InnoPack North America (24-26 April, 2018 at the Pennsylvania Convention Center – Philadelphia, USA)

 

About UBM India: 

UBM India is India's leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences & seminars. UBM India hosts over 25 large scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia. For further details, please visit ubmindia.in.

 

For media enquiries, please contact:

Alex Heeley or Alex Allsop

De Facto Communications

T: +44 (0) 203 735 8168

E: a.heeley@defacto.com / a.allsop@defacto.com